[The basic concept of therapeutic approaches for DMD]

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Duchenne muscular dystrophy (DMD) is a prevalent childhood neuromuscular disorder.
• While care standards have improved life expectancy, DMD still causes progressive motor and cardiac decline.
• Corticosteroids were the primary treatment to modestly slow disease progression.

Purpose of the Study:

• To review novel therapeutic strategies for DMD.
• To discuss the molecular mechanisms and clinical trial progress of these new treatments.
• To highlight the potential of innovative therapies to transform DMD patient outcomes.

Main Methods:

• Literature review of recent clinical trials and therapeutic approaches for DMD.
• Analysis of the molecular mechanisms underlying novel DMD treatments.
• Synthesis of current research on innovative strategies for managing DMD.

Main Results:

• Significant advancements in understanding DMD molecular pathology.
• Emerging therapeutic strategies demonstrate potential in clinical trials.
• Novel treatments offer hope for profoundly modifying DMD's disease course.

Conclusions:

• Innovative therapies are emerging for Duchenne muscular dystrophy.
• These new approaches target underlying molecular mechanisms.
• Therapeutic advances hold potential to significantly change DMD prognosis.